Fate of Sudden Deafness Occurring in the Only Hearing Ear: Outcomes and Timing to Consider Cochlear Implantation.
10.3346/jkms.2010.25.2.283
- Author:
Seung Su LEE
1
;
Hyong Ho CHO
;
Chul Ho JANG
;
Yong Bum CHO
Author Information
1. Department of Otolaryngology and Head and Neck Surgery, Chonnam National University Medical School, Gwangju, Korea. victocho@hanmail.net
- Publication Type:Original Article
- Keywords:
Hearing Loss, Sudden;
Cochlear Implantation;
Treatment Outcome
- MeSH:
Adolescent;
Adult;
Aged;
Aged, 80 and over;
Child;
*Cochlear Implantation;
Demography;
Female;
Hearing Loss, Sudden/surgery/*therapy;
Hearing Loss, Unilateral/*diagnosis;
Humans;
Male;
Middle Aged;
Patient Selection;
Retrospective Studies;
Severity of Illness Index;
Treatment Outcome
- From:Journal of Korean Medical Science
2010;25(2):283-286
- CountryRepublic of Korea
- Language:English
-
Abstract:
The present study was undertaken to learn the outcome of patients with idiopathic sudden sensorineural hearing loss (ISSNHL) in their only hearing ear. Timing to conduct a cochlear implantation was also determined in those who did not recover the hearing. The study group comprised 25 patients who confronted ISSNHL in their only hearing ear. A total of 192 patients, who had ISSNHL in one ear and had normal contralateral ear, served as the control. Demographically there were no significant differences between the groups. The recovery rate was similar between the groups: 64.0% in the experimental and 62.5% in the control group. The duration until the recovery of ISSNHL in the only hearing ear was 5-90 days (average 17.6 days). In the experimental group, 8 patients did not recover from ISSNHL, and underwent cochlear implantation in 6 with satisfactory results. These results suggest that the same treatment is applicable for patients with ISSNHL regardless of whether their contralateral ear is deaf or normal. For those who do not recover from ISSNHL in their only hearing ear, culminating in bilateral deafness, we may consider further definitive treatment including cochlear implantation as early as 3 months after initiating the treatment of ISSNHL.
